Ontario Pharmacists and Avricore Health Partner to Expand HealthTab™ in Community Pharmacies and Enhance Patient Care
18 nov. 2019 08h30 HE
|
Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 18, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) and the Ontario Pharmacists Association (OPA) are...
Prevent Cancer Foundation® awards $250,000 in community grants
16 août 2019 13h18 HE
|
Prevent Cancer Foundation
Alexandria, Va., Aug. 16, 2019 (GLOBE NEWSWIRE) -- Through its community grants program, the Prevent Cancer Foundation® is proud to support 10 projects focused on increasing cancer prevention and...
Think you’re “Too Young for This Sh*t?” Think again.
25 mars 2019 13h13 HE
|
Prevent Cancer Foundation
Alexandria, Va., March 25, 2019 (GLOBE NEWSWIRE) -- It’s a common misconception that colorectal cancer affects only older people—but today, more adults under the recommended screening age are being...
COMS Interactive Releases an Enhanced Design, Skilled Nursing Facilities Already Seeing Value
02 févr. 2017 11h35 HE
|
COMS Interactive
BROADVIEW HEIGHTS, Ohio, Feb. 02, 2017 (GLOBE NEWSWIRE) -- COMS Interactive, the clinical care and quality improvement leader in the senior care market, released a new assessment design and...
DiamiR Announces Oral Presentation at 2016 Alzheimer's Association International Conference
21 juil. 2016 08h30 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ --(Marketwired - July 21, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that the...
DiamiR Announces Oral Presentation at Biomarkers Summit 2016
18 mars 2016 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 18, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today that...
Provista Diagnostics Announces the Closing of $6.0 Million Financing
04 août 2015 15h20 HE
|
Provista Diagnostics, Inc.
NEW YORK, NY, Aug. 4, 2015 (GLOBE NEWSWIRE) -- August 4, 2015: Provista Diagnostics, Inc., a privately held molecular diagnostics company headquartered in New York, today announced the closing of $6.0...
DiamiR Announces Presentation at Extracellular Biomarkers Summit 2015
11 mars 2015 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - March 11, 2015) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Poster Presentation at the Clinical Trials on Alzheimer's Disease 2014
17 nov. 2014 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 17, 2014) - DiamiR Biosciences, a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today that the company's...
DiamiR Announces Publication and Discusses Merits of Universal Screening Test Based on Organ-Enriched microRNA Signatures
03 nov. 2014 08h02 HE
|
DiamiR Biosciences Corp.
MONMOUTH JUNCTION, NJ--(Marketwired - November 03, 2014) - DiamiR Biosciences Corp., a developer of innovative diagnostic tests for neurodegenerative and other diseases, announced today the...